While no formal clinical trials of this specific combination have been publicly reported as of early 2026, the theoretical basis for synergy is compelling based on the distinct yet complementary mechanisms of each compound [5]
And as glutathione combats free radicals that can lead to premature aging, it can reduce the visibility of common signs of aging (e.g
Use of GLP-1 drugs is highest among adults who report being diagnosed with conditions these drugs are prescribed to treat, including those who have ever been told by a doctor that they have diabetes (57% ever used, including 45% currently using), heart disease (40% ever, 29% currently), and those that have been told by a doctor that they are overweight or obese in the past five years (34% ever, 23% currently)
Early GLP-1 RAs (exenatide) [archived link] and exenatide ER [archived link]) were designed after a GLP-1 version found in Gila monster venom [archived link]
Sun Exposure Excessive UV exposure can limit treatment outcomes